High-intensity focused ultrasound therapy for clinically localized prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 4, 2006, Pages 439-443

  Lee, H M ^a   Hong, J H ^a   Choi, H Y ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; DEVICE; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REGRESSION ANALYSIS; SAFETY; TRANSURETHRAL RESECTION; TREATMENT FAILURE; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL; URETHRAL STRICTURE; URINARY INCONTINENCE, STRESS; URINARY RETENTION;

EID: 33751561781     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500901     Document Type: Article

References (22)

1. Iselin CE, Robertson JE, Paulson DF. Radical perineal prostatectomy: oncological outcome during a 20-year period. J Urol 1999; 161: 163-168.
2. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin N Am 2001; 28: 555-565.
3. Augustin H, Hammerer P, Graefen M, Palisaar J, Noldus J, Fernandez S et al. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol 2003; 43: 113-118.
4. Beerlage HP, Thuroff S, Madersbacher S, Zlotta AR, Aus G, de Reijke TM et al. Current status of minimally invasive treatment options for localized prostate carcinoma. Eur Urol 2000; 37: 2-13.
5. Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol 2003; 76: 590-599.
6. Colombel M, Gelet A. Principles and results of high-intensity focused ultrasound for localized prostate cancer. Prostate Cancer Prostatic Dis 2004; 7: 289-294.
7. Rebillard X, Gelet A, Davin JL, Soulie M, Prapotnich D, Cathelineau X et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 2005; 19: 693-701.
8. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974.
9. Consensus statement: Guidelines for PSA following radiation therapy. American society for therapeutic radiology and oncology consensus panel. Int J Radiat Oncol Biol Phys 1997; 1035-1041.
10. Gelet A, Chapelon JY, Bouvier R, Souchon R, Pangaud C, Abdelrahim AF et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996; 29: 174-183.
11. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: Preliminary results. J Urol 1999; 161: 156-162.
12. Chaussy CG, Thuroff S. High-intensive focused ultrasound localized prostate cancer. J Endourol 2000; 14: 293-299.
13. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound the treatment of localized prostate cancer: Factors influencing the outcome. Eur Urol 2001; 40: 124-129.
14. Thuroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 2003; 17: 673-677.
15. Blana A, Walter B, Rogenhofer S, Wieland WF. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004; 63: 297-300.
16. Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248-252.
17. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: Feasibility study. J Urol 2004; 171: 2265-2267.
18. Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 2006; 97: 56-61.
19. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer 2000; 89: 1800-1809.
20. Augustin H, Erbersdobler A, Graefen M, Fernandez S, Palisaar J, Huland H et al. Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones. Prostate 2003; 55: 48-54.
21. Kavadi VS, Zagars GK, Pollack A. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications. Int J Radiat Oncol Biol Phys 1994; 30: 279-287.
22. Critz FA, Levinson AK, Williams WH, Holladay CT, Griffin VD, Holladay DA. Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy. J Urol 1999; 161: 1199-1203; discussion 1195-1203.